# Executive Findings & Clinical Outcomes Report
**Target Audience:** Chief Medical Officer, Hospital Operations Committee, Clinical Analytics Lead  
**Scope:** 984 Inpatient Encounters | 15 Conditions | Readmission Risk Analytics  
**Author:** Rishi Dappu, Data Analyst

---

## 1. Executive Summary
This project evaluates hospital resource utilization, readmission risk factors, and the economics of post-discharge transitional care. Our findings demonstrate that readmission expense is heavily concentrated in a small patient subset, and targeted risk-based patient enrollment delivers positive operational ROI while blanket programs incur heavy financial losses.

---

## 2. Key Analytical Insights
1. **Severe Cost Asymmetry:** Readmitted patients represent 26.8% of admissions but generate 43.8% of inpatient expense.
2. **Clinical Baseline Power:** Medical diagnosis alone explains the vast majority of readmission risk (0.929 baseline ROC-AUC).
3. **Intervention Economics:** Enrolling the top-quartile high-risk cohort (246 patients) generates **Rs. 2.98L in net cost benefit**, whereas blanket enrollment loses **Rs. 10.4L**.

---

## 3. Recommendations
1. Deploy transitional care coordinators specifically targeting high-risk cardiac and diabetic inpatient discharges.
2. Establish transparent baseline benchmarking to prevent blind trust in opaque ML algorithms.
